Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 2Active not recruiting 2

Sponsor Class

OTHER 4

Study Type

Observational 3Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 2Genitourinary 1

Conditions

Neoplasms 2Prostatic Neoplasms 1Hereditary Cancer 1Adenocarcinoma 1

Interventions

pembrolizumab 602Cyclophosphamide 545Magnetic Resonance Spectroscopy 524Radiotherapy 513Specimen Handling 506Nivolumab 412Cisplatin 380Carboplatin 368Biopsy 306Blood Specimen Collection 302Radiosurgery 290Paclitaxel 280Surveys and Questionnaires 270Gemcitabine 270Standard of Care 267Drug Therapy 263Dexamethasone 263fludarabine 262Bevacizumab 253venetoclax 251Oxaliplatin 209Capecitabine 201Rituximab 198Radiation 192Fluorouracil 189Ipilimumab 188durvalumab 184Doxorubicin 179Etoposide 176atezolizumab 175

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Longitudinal Studies × 1 year × Clear all
NCT06157801 2026-03-04

Evaluation of Hereditary Cancer Educational Videos

M.D. Anderson Cancer Center

Active not recruiting
43 enrolled

Hereditary Cancer

NCT07339943 2026-01-14

MicroUSgFLA

University Health Network, Toronto

Phase NA Recruiting
7 enrolled
Genitourinary

Adenocarcinoma, Prostatic Neoplasms

NCT06270602 2025-12-22

The ONCOCAMP Study

National Cancer Institute, Naples

Recruiting
15,000 enrolled
Tumor-Agnostic

Neoplasms

NCT02159742 2025-07-02

Prospective Follow-up of Outcomes in Patients Receiving Photodynamic Therapy for Neoplastic Diseases

Abramson Cancer Center at Penn Medicine

Active not recruiting
400 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡